Empacoza Trio XR 25/5/1000 mg 30 tablets
Zeta Pharma
Zeta Pharma
Overview
Empacoza Trio XR 25/5/1000 mg is an extended-release combination tablet from Zeta Pharma for adults with type 2 diabetes mellitus, supplied as 30 tablets. It brings together three complementary medicines in one fixed-dose formulation, intended as an adjunct to diet and exercise to improve glycemic control.
Key Benefits
Each tablet combines empagliflozin, an SGLT2 inhibitor that helps the body remove excess glucose through urine, with linagliptin, a DPP-4 inhibitor that supports insulin release and reduces glucagon production, and metformin, which lowers glucose output from the liver and improves the body's sensitivity to insulin. The extended-release format is designed for convenient once-daily use, replacing three separate medicines with a single tablet when combination therapy is needed.
How to Use
Take exactly as prescribed by your doctor or pharmacist.
Active Ingredients
Empagliflozin, linagliptin, metformin.
Precautions
Prescription medicine. Not for use in type 1 diabetes or without medical supervision. Discuss your full medical history with your doctor before starting treatment.
Storage
Store below 25°C in a dry place, away from light and out of reach of children.